CD8A and melanoma: Indeed, this notion has been recently shown in a cohort of melanoma patients treated with anti-PD-1 therapy (44) and supported by Bhatt et al., who made the interesting observation that specific CD8+ and CD4+ anti-HPV T-cell reactivity dropped after radical CRT (45).